The Drug Enforcement Administration (DEA) is proposing a drastic increase in the legal production of marijuana and psychedelics including psilocybin, LSD, MDMA and DMT to be utilized in research projects next year…. Sounds like the DEA has entered the “if ya can’t beat em’ Join em’” state of mind.
“significant increase in the use of schedule I hallucinogenic controlled substances for research and clinical trial purposes,” The DEO Memo released Monday seeking authorized manufacturers to meet that growing demand.
The “DEA supports regulated research with schedule I controlled substances” – DEA statement from the Federal Register notice